Cargando…

Cardiac hypertrophy in mice expressing unphosphorylatable phospholemman

AIMS: Elevation of intracellular Na in the failing myocardium contributes to contractile dysfunction, the negative force–frequency relationship, and arrhythmias. Although phospholemman (PLM) is recognized to form the link between signalling pathways and Na/K pump activity, the possibility that defec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boguslavskyi, Andrii, Pavlovic, Davor, Aughton, Karen, Clark, James E., Howie, Jacqueline, Fuller, William, Shattock, Michael J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2014
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4174889/ https://www.ncbi.nlm.nih.gov/pubmed/25103111 http://dx.doi.org/10.1093/cvr/cvu182

Ejemplares similares

Nitric oxide regulates cardiac intracellular Na(+) and Ca(2 +) by modulating Na/K ATPase via PKCε and phospholemman-dependent mechanism()
por: Pavlovic, Davor, et al.
Publicado: (2013)

Phospholemman Phosphorylation Regulates Vascular Tone, Blood Pressure, and Hypertension in Mice and Humans
por: Boguslavskyi, Andrii, et al.
Publicado: (2020)

Phospholemman Ser69 phosphorylation contributes to sildenafil-induced cardioprotection against reperfusion injury
por: Madhani, Melanie, et al.
Publicado: (2010)

Expression and regulation of type 2A protein phosphatases and alpha4 signalling in cardiac health and hypertrophy
por: Eleftheriadou, Olga, et al.
Publicado: (2017)

Dynamic but discordant alterations in zDHHC5 expression and palmitoylation of its substrates in cardiac pathologies
por: Main, Alice, et al.
Publicado: (2022)

Multiple quantum filtered (23)Na NMR in the Langendorff perfused mouse heart: Ratio of triple/double quantum filtered signals correlates with [Na](i)
por: Eykyn, Thomas R., et al.
Publicado: (2015)

SGLT2 inhibitors and the cardiac Na(+)/H(+) exchanger-1: the plot thickens
por: Chung, Yu Jin, et al.
Publicado: (2021)

Development of a high-affinity peptide that prevents phospholemman (PLM) inhibition of the sodium/calcium exchanger 1 (NCX1)
por: Wanichawan, Pimthanya, et al.
Publicado: (2016)

Impact of phosphomimetic and non-phosphorylatable mutations of phospholemman on L-type calcium channels gating in HEK 293T cells
por: Guo, Kai, et al.
Publicado: (2015)

Regulation of the cardiac sodium pump
por: Fuller, W., et al.
Publicado: (2012)

Chronic Nicotine Modifies Skeletal Muscle Na,K-ATPase Activity through Its Interaction with the Nicotinic Acetylcholine Receptor and Phospholemman
por: Chibalin, Alexander V., et al.
Publicado: (2012)

Inhibition of K(+) Transport through Na(+), K(+)-ATPase by Capsazepine: Role of Membrane Span 10 of the α-Subunit in the Modulation of Ion Gating
por: Mahmmoud, Yasser A., et al.
Publicado: (2014)

Control of protein palmitoylation by regulating substrate recruitment to a zDHHC-protein acyltransferase
por: Plain, Fiona, et al.
Publicado: (2020)

Off-target effects of sodium-glucose co-transporter 2 blockers: empagliflozin does not inhibit Na(+)/H(+) exchanger-1 or lower [Na(+)](i) in the heart
por: Chung, Yu Jin, et al.
Publicado: (2020)

Cardiomyocyte BRAF is a key signalling intermediate in cardiac hypertrophy in mice
por: Alharbi, Hajed O., et al.
Publicado: (2022)

Is there a causal link between intracellular Na elevation and metabolic remodelling in cardiac hypertrophy?
por: Aksentijevic, Dunja, et al.
Publicado: (2018)

Endurance Exercise Effects on Cardiac Hypertrophy in Mice
por: Han, Gun-Soo
Publicado: (2014)

Na(+)/Ca(2+) exchange and Na(+)/K(+)-ATPase in the heart
por: Shattock, Michael J, et al.
Publicado: (2015)

The etiology of cardiac hypertrophy in infants
por: Stegeman, Raymond, et al.
Publicado: (2021)

Cardiac Hypertrophy
por: DaCosta,
Publicado: (1891)

THE CAPACITY OF THE CORONARY BED IN CARDIAC HYPERTROPHY
por: Dock, William
Publicado: (1941)

Cardiac Expression of Factor X Mediates Cardiac Hypertrophy and Fibrosis in Pressure Overload
por: Guo, Xinji, et al.
Publicado: (2020)

Three TF Co-expression Modules Regulate Pressure-Overload Cardiac Hypertrophy in Male Mice
por: Chang, Yao-Ming, et al.
Publicado: (2017)

Sympathetic Nervous Regulation of Calcium and Action Potential Alternans in the Intact Heart
por: Winter, James, et al.
Publicado: (2018)

Cardiac hypertrophy at autopsy
por: Basso, Cristina, et al.
Publicado: (2021)

Cardiac Hypertrophy and Dilatation
por: Davis, M. T.
Publicado: (1915)

Genome-wide expression patterns in physiological cardiac hypertrophy
por: Drozdov, Ignat, et al.
Publicado: (2010)

Translating Translation to Mechanisms of Cardiac Hypertrophy
por: Zeitz, Michael J., et al.
Publicado: (2020)

Renal ischemia/reperfusion-induced cardiac hypertrophy in mice: Cardiac morphological and morphometric characterization
por: Cirino-Silva, Rogério, et al.
Publicado: (2017)

Complex Relationship Between Cardiac Fibroblasts and Cardiomyocytes in Health and Disease
por: Hall, Caitlin, et al.
Publicado: (2021)

Reversible cardiac hypertrophy induced by PEG-coated gold nanoparticles in mice
por: Yang, Chengzhi, et al.
Publicado: (2016)

Perinatal DDT Exposure Induces Hypertension and Cardiac Hypertrophy in Adult Mice
por: La Merrill, Michele A., et al.
Publicado: (2016)

Cardiac hypertrophy limits infarct expansion after myocardial infarction in mice
por: Iismaa, Siiri E., et al.
Publicado: (2018)

Ivabradine promotes angiogenesis and reduces cardiac hypertrophy in mice with myocardial infarction
por: Wu, Xiangqi, et al.
Publicado: (2018)

Myeloid MKL1 Disseminates Cues to Promote Cardiac Hypertrophy in Mice
por: Liu, Li, et al.
Publicado: (2021)

Cardiomyocyte BRAF and type 1 RAF inhibitors promote cardiomyocyte and cardiac hypertrophy in mice in vivo
por: Clerk, Angela, et al.
Publicado: (2022)

Cardiac Expression of Factor X Mediates Cardiac Hypertrophy and Fibrosis in Pressure Overload
Publicado: (2022)

Circular RNA expression in isoproterenol hydrochloride-induced cardiac hypertrophy
por: Yang, Ming-Hui, et al.
Publicado: (2020)

Cardiac Hypertrophy in Newborn Infants
por: Miller, Herbert C.
Publicado: (1944)

cGMP and cardiac hypertrophy
por: Perera, Ruwan K, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_m6mul51a2a6j0jpr8sfl120blt